Global Preimplantation Genetic Diagnosis (PGD) Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Preimplantation Genetic Diagnosis (PGD) market size was valued at US$ million in 2023. With growing demand in downstream market, the Preimplantation Genetic Diagnosis (PGD) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Preimplantation Genetic Diagnosis (PGD) market. Preimplantation Genetic Diagnosis (PGD) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Preimplantation Genetic Diagnosis (PGD). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Preimplantation Genetic Diagnosis (PGD) market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Preimplantation Genetic Diagnosis (PGD) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Preimplantation Genetic Diagnosis (PGD) market. It may include historical data, market segmentation by Type (e.g., Chromosomal Abnormalities, Gender Selection), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Preimplantation Genetic Diagnosis (PGD) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Preimplantation Genetic Diagnosis (PGD) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Preimplantation Genetic Diagnosis (PGD) industry. This include advancements in Preimplantation Genetic Diagnosis (PGD) technology, Preimplantation Genetic Diagnosis (PGD) new entrants, Preimplantation Genetic Diagnosis (PGD) new investment, and other innovations that are shaping the future of Preimplantation Genetic Diagnosis (PGD).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Preimplantation Genetic Diagnosis (PGD) market. It includes factors influencing customer ' purchasing decisions, preferences for Preimplantation Genetic Diagnosis (PGD) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Preimplantation Genetic Diagnosis (PGD) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Preimplantation Genetic Diagnosis (PGD) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Preimplantation Genetic Diagnosis (PGD) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Preimplantation Genetic Diagnosis (PGD) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Preimplantation Genetic Diagnosis (PGD) market.
Market Segmentation:
Preimplantation Genetic Diagnosis (PGD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Preimplantation Genetic Diagnosis (PGD) market size was valued at US$ million in 2023. With growing demand in downstream market, the Preimplantation Genetic Diagnosis (PGD) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Preimplantation Genetic Diagnosis (PGD) market. Preimplantation Genetic Diagnosis (PGD) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Preimplantation Genetic Diagnosis (PGD). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Preimplantation Genetic Diagnosis (PGD) market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Preimplantation Genetic Diagnosis (PGD) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Preimplantation Genetic Diagnosis (PGD) market. It may include historical data, market segmentation by Type (e.g., Chromosomal Abnormalities, Gender Selection), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Preimplantation Genetic Diagnosis (PGD) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Preimplantation Genetic Diagnosis (PGD) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Preimplantation Genetic Diagnosis (PGD) industry. This include advancements in Preimplantation Genetic Diagnosis (PGD) technology, Preimplantation Genetic Diagnosis (PGD) new entrants, Preimplantation Genetic Diagnosis (PGD) new investment, and other innovations that are shaping the future of Preimplantation Genetic Diagnosis (PGD).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Preimplantation Genetic Diagnosis (PGD) market. It includes factors influencing customer ' purchasing decisions, preferences for Preimplantation Genetic Diagnosis (PGD) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Preimplantation Genetic Diagnosis (PGD) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Preimplantation Genetic Diagnosis (PGD) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Preimplantation Genetic Diagnosis (PGD) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Preimplantation Genetic Diagnosis (PGD) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Preimplantation Genetic Diagnosis (PGD) market.
Market Segmentation:
Preimplantation Genetic Diagnosis (PGD) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Chromosomal Abnormalities
- Gender Selection
- X-linked Diseases
- Aneuploidy
- Single Gene Disorders
- Others
- Maternity Centers & Fertility Clinics
- Hospitals, Diagnostic Labs, and Service Providers
- Research Laboratories & Academic Institutes
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Illumina
- Thermo Fisher
- Agilent Technologies
- PerkinElmer
- Coopersurgical
- Abbott Laboratories
- Natera
- Takara Bio
- Oxford Gene Technology
- Yikon Genomics
- Progenesis
- Beijing Genomics Institute
- Invitae
- Invicta Genetics
- Combimatrix
- Genea Limited
- Bioarray
- Quest Diagnostics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size 2019-2030
2.1.2 Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Preimplantation Genetic Diagnosis (PGD) Segment by Type
2.2.1 Chromosomal Abnormalities
2.2.2 Gender Selection
2.2.3 X-linked Diseases
2.2.4 Aneuploidy
2.2.5 Single Gene Disorders
2.2.6 Others
2.3 Preimplantation Genetic Diagnosis (PGD) Market Size by Type
2.3.1 Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
2.4 Preimplantation Genetic Diagnosis (PGD) Segment by Application
2.4.1 Maternity Centers & Fertility Clinics
2.4.2 Hospitals, Diagnostic Labs, and Service Providers
2.4.3 Research Laboratories & Academic Institutes
2.5 Preimplantation Genetic Diagnosis (PGD) Market Size by Application
2.5.1 Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
3 PREIMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET SIZE BY PLAYER
3.1 Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Players
3.1.1 Global Preimplantation Genetic Diagnosis (PGD) Revenue by Players (2019-2024)
3.1.2 Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2019-2024)
3.2 Global Preimplantation Genetic Diagnosis (PGD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PREIMPLANTATION GENETIC DIAGNOSIS (PGD) BY REGIONS
4.1 Preimplantation Genetic Diagnosis (PGD) Market Size by Regions (2019-2024)
4.2 Americas Preimplantation Genetic Diagnosis (PGD) Market Size Growth (2019-2024)
4.3 APAC Preimplantation Genetic Diagnosis (PGD) Market Size Growth (2019-2024)
4.4 Europe Preimplantation Genetic Diagnosis (PGD) Market Size Growth (2019-2024)
4.5 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024)
5.2 Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024)
5.3 Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2019-2024)
6.2 APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024)
6.3 APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Preimplantation Genetic Diagnosis (PGD) by Country (2019-2024)
7.2 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024)
7.3 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) by Region (2019-2024)
8.2 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024)
8.3 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PREIMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET FORECAST
10.1 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Regions (2025-2030)
10.1.1 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Regions (2025-2030)
10.1.2 Americas Preimplantation Genetic Diagnosis (PGD) Forecast
10.1.3 APAC Preimplantation Genetic Diagnosis (PGD) Forecast
10.1.4 Europe Preimplantation Genetic Diagnosis (PGD) Forecast
10.1.5 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Forecast
10.2 Americas Preimplantation Genetic Diagnosis (PGD) Forecast by Country (2025-2030)
10.2.1 United States Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.2.2 Canada Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.2.3 Mexico Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.2.4 Brazil Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.3 APAC Preimplantation Genetic Diagnosis (PGD) Forecast by Region (2025-2030)
10.3.1 China Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.3.2 Japan Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.3.3 Korea Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.3.4 Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.3.5 India Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.3.6 Australia Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.4 Europe Preimplantation Genetic Diagnosis (PGD) Forecast by Country (2025-2030)
10.4.1 Germany Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.4.2 France Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.4.3 UK Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.4.4 Italy Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.4.5 Russia Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.5 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Forecast by Region (2025-2030)
10.5.1 Egypt Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.5.2 South Africa Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.5.3 Israel Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.5.4 Turkey Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.5.5 GCC Countries Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.6 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Type (2025-2030)
10.7 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina Preimplantation Genetic Diagnosis (PGD) Product Offered
11.1.3 Illumina Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Information
11.2.2 Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Product Offered
11.2.3 Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Main Business Overview
11.2.5 Thermo Fisher Latest Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Information
11.3.2 Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Product Offered
11.3.3 Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Agilent Technologies Main Business Overview
11.3.5 Agilent Technologies Latest Developments
11.4 PerkinElmer
11.4.1 PerkinElmer Company Information
11.4.2 PerkinElmer Preimplantation Genetic Diagnosis (PGD) Product Offered
11.4.3 PerkinElmer Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 PerkinElmer Main Business Overview
11.4.5 PerkinElmer Latest Developments
11.5 Coopersurgical
11.5.1 Coopersurgical Company Information
11.5.2 Coopersurgical Preimplantation Genetic Diagnosis (PGD) Product Offered
11.5.3 Coopersurgical Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Coopersurgical Main Business Overview
11.5.5 Coopersurgical Latest Developments
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Information
11.6.2 Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Product Offered
11.6.3 Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Abbott Laboratories Main Business Overview
11.6.5 Abbott Laboratories Latest Developments
11.7 Natera
11.7.1 Natera Company Information
11.7.2 Natera Preimplantation Genetic Diagnosis (PGD) Product Offered
11.7.3 Natera Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Natera Main Business Overview
11.7.5 Natera Latest Developments
11.8 Takara Bio
11.8.1 Takara Bio Company Information
11.8.2 Takara Bio Preimplantation Genetic Diagnosis (PGD) Product Offered
11.8.3 Takara Bio Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Takara Bio Main Business Overview
11.8.5 Takara Bio Latest Developments
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Information
11.9.2 Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Product Offered
11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Oxford Gene Technology Main Business Overview
11.9.5 Oxford Gene Technology Latest Developments
11.10 Yikon Genomics
11.10.1 Yikon Genomics Company Information
11.10.2 Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Product Offered
11.10.3 Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Yikon Genomics Main Business Overview
11.10.5 Yikon Genomics Latest Developments
11.11 Progenesis
11.11.1 Progenesis Company Information
11.11.2 Progenesis Preimplantation Genetic Diagnosis (PGD) Product Offered
11.11.3 Progenesis Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Progenesis Main Business Overview
11.11.5 Progenesis Latest Developments
11.12 Beijing Genomics Institute
11.12.1 Beijing Genomics Institute Company Information
11.12.2 Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Product Offered
11.12.3 Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Beijing Genomics Institute Main Business Overview
11.12.5 Beijing Genomics Institute Latest Developments
11.13 Invitae
11.13.1 Invitae Company Information
11.13.2 Invitae Preimplantation Genetic Diagnosis (PGD) Product Offered
11.13.3 Invitae Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Invitae Main Business Overview
11.13.5 Invitae Latest Developments
11.14 Invicta Genetics
11.14.1 Invicta Genetics Company Information
11.14.2 Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Product Offered
11.14.3 Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Invicta Genetics Main Business Overview
11.14.5 Invicta Genetics Latest Developments
11.15 Combimatrix
11.15.1 Combimatrix Company Information
11.15.2 Combimatrix Preimplantation Genetic Diagnosis (PGD) Product Offered
11.15.3 Combimatrix Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Combimatrix Main Business Overview
11.15.5 Combimatrix Latest Developments
11.16 Genea Limited
11.16.1 Genea Limited Company Information
11.16.2 Genea Limited Preimplantation Genetic Diagnosis (PGD) Product Offered
11.16.3 Genea Limited Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Genea Limited Main Business Overview
11.16.5 Genea Limited Latest Developments
11.17 Bioarray
11.17.1 Bioarray Company Information
11.17.2 Bioarray Preimplantation Genetic Diagnosis (PGD) Product Offered
11.17.3 Bioarray Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Bioarray Main Business Overview
11.17.5 Bioarray Latest Developments
11.18 Quest Diagnostics
11.18.1 Quest Diagnostics Company Information
11.18.2 Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Product Offered
11.18.3 Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Quest Diagnostics Main Business Overview
11.18.5 Quest Diagnostics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Preimplantation Genetic Diagnosis (PGD) Market Size 2019-2030
2.1.2 Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Preimplantation Genetic Diagnosis (PGD) Segment by Type
2.2.1 Chromosomal Abnormalities
2.2.2 Gender Selection
2.2.3 X-linked Diseases
2.2.4 Aneuploidy
2.2.5 Single Gene Disorders
2.2.6 Others
2.3 Preimplantation Genetic Diagnosis (PGD) Market Size by Type
2.3.1 Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
2.4 Preimplantation Genetic Diagnosis (PGD) Segment by Application
2.4.1 Maternity Centers & Fertility Clinics
2.4.2 Hospitals, Diagnostic Labs, and Service Providers
2.4.3 Research Laboratories & Academic Institutes
2.5 Preimplantation Genetic Diagnosis (PGD) Market Size by Application
2.5.1 Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
3 PREIMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET SIZE BY PLAYER
3.1 Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Players
3.1.1 Global Preimplantation Genetic Diagnosis (PGD) Revenue by Players (2019-2024)
3.1.2 Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2019-2024)
3.2 Global Preimplantation Genetic Diagnosis (PGD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PREIMPLANTATION GENETIC DIAGNOSIS (PGD) BY REGIONS
4.1 Preimplantation Genetic Diagnosis (PGD) Market Size by Regions (2019-2024)
4.2 Americas Preimplantation Genetic Diagnosis (PGD) Market Size Growth (2019-2024)
4.3 APAC Preimplantation Genetic Diagnosis (PGD) Market Size Growth (2019-2024)
4.4 Europe Preimplantation Genetic Diagnosis (PGD) Market Size Growth (2019-2024)
4.5 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024)
5.2 Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024)
5.3 Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2019-2024)
6.2 APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024)
6.3 APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Preimplantation Genetic Diagnosis (PGD) by Country (2019-2024)
7.2 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024)
7.3 Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) by Region (2019-2024)
8.2 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024)
8.3 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PREIMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET FORECAST
10.1 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Regions (2025-2030)
10.1.1 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Regions (2025-2030)
10.1.2 Americas Preimplantation Genetic Diagnosis (PGD) Forecast
10.1.3 APAC Preimplantation Genetic Diagnosis (PGD) Forecast
10.1.4 Europe Preimplantation Genetic Diagnosis (PGD) Forecast
10.1.5 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Forecast
10.2 Americas Preimplantation Genetic Diagnosis (PGD) Forecast by Country (2025-2030)
10.2.1 United States Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.2.2 Canada Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.2.3 Mexico Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.2.4 Brazil Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.3 APAC Preimplantation Genetic Diagnosis (PGD) Forecast by Region (2025-2030)
10.3.1 China Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.3.2 Japan Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.3.3 Korea Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.3.4 Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.3.5 India Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.3.6 Australia Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.4 Europe Preimplantation Genetic Diagnosis (PGD) Forecast by Country (2025-2030)
10.4.1 Germany Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.4.2 France Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.4.3 UK Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.4.4 Italy Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.4.5 Russia Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.5 Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Forecast by Region (2025-2030)
10.5.1 Egypt Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.5.2 South Africa Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.5.3 Israel Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.5.4 Turkey Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.5.5 GCC Countries Preimplantation Genetic Diagnosis (PGD) Market Forecast
10.6 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Type (2025-2030)
10.7 Global Preimplantation Genetic Diagnosis (PGD) Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina Preimplantation Genetic Diagnosis (PGD) Product Offered
11.1.3 Illumina Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Information
11.2.2 Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Product Offered
11.2.3 Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Main Business Overview
11.2.5 Thermo Fisher Latest Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Information
11.3.2 Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Product Offered
11.3.3 Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Agilent Technologies Main Business Overview
11.3.5 Agilent Technologies Latest Developments
11.4 PerkinElmer
11.4.1 PerkinElmer Company Information
11.4.2 PerkinElmer Preimplantation Genetic Diagnosis (PGD) Product Offered
11.4.3 PerkinElmer Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 PerkinElmer Main Business Overview
11.4.5 PerkinElmer Latest Developments
11.5 Coopersurgical
11.5.1 Coopersurgical Company Information
11.5.2 Coopersurgical Preimplantation Genetic Diagnosis (PGD) Product Offered
11.5.3 Coopersurgical Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Coopersurgical Main Business Overview
11.5.5 Coopersurgical Latest Developments
11.6 Abbott Laboratories
11.6.1 Abbott Laboratories Company Information
11.6.2 Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Product Offered
11.6.3 Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Abbott Laboratories Main Business Overview
11.6.5 Abbott Laboratories Latest Developments
11.7 Natera
11.7.1 Natera Company Information
11.7.2 Natera Preimplantation Genetic Diagnosis (PGD) Product Offered
11.7.3 Natera Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Natera Main Business Overview
11.7.5 Natera Latest Developments
11.8 Takara Bio
11.8.1 Takara Bio Company Information
11.8.2 Takara Bio Preimplantation Genetic Diagnosis (PGD) Product Offered
11.8.3 Takara Bio Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Takara Bio Main Business Overview
11.8.5 Takara Bio Latest Developments
11.9 Oxford Gene Technology
11.9.1 Oxford Gene Technology Company Information
11.9.2 Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Product Offered
11.9.3 Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Oxford Gene Technology Main Business Overview
11.9.5 Oxford Gene Technology Latest Developments
11.10 Yikon Genomics
11.10.1 Yikon Genomics Company Information
11.10.2 Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Product Offered
11.10.3 Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Yikon Genomics Main Business Overview
11.10.5 Yikon Genomics Latest Developments
11.11 Progenesis
11.11.1 Progenesis Company Information
11.11.2 Progenesis Preimplantation Genetic Diagnosis (PGD) Product Offered
11.11.3 Progenesis Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Progenesis Main Business Overview
11.11.5 Progenesis Latest Developments
11.12 Beijing Genomics Institute
11.12.1 Beijing Genomics Institute Company Information
11.12.2 Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Product Offered
11.12.3 Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Beijing Genomics Institute Main Business Overview
11.12.5 Beijing Genomics Institute Latest Developments
11.13 Invitae
11.13.1 Invitae Company Information
11.13.2 Invitae Preimplantation Genetic Diagnosis (PGD) Product Offered
11.13.3 Invitae Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Invitae Main Business Overview
11.13.5 Invitae Latest Developments
11.14 Invicta Genetics
11.14.1 Invicta Genetics Company Information
11.14.2 Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Product Offered
11.14.3 Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Invicta Genetics Main Business Overview
11.14.5 Invicta Genetics Latest Developments
11.15 Combimatrix
11.15.1 Combimatrix Company Information
11.15.2 Combimatrix Preimplantation Genetic Diagnosis (PGD) Product Offered
11.15.3 Combimatrix Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Combimatrix Main Business Overview
11.15.5 Combimatrix Latest Developments
11.16 Genea Limited
11.16.1 Genea Limited Company Information
11.16.2 Genea Limited Preimplantation Genetic Diagnosis (PGD) Product Offered
11.16.3 Genea Limited Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Genea Limited Main Business Overview
11.16.5 Genea Limited Latest Developments
11.17 Bioarray
11.17.1 Bioarray Company Information
11.17.2 Bioarray Preimplantation Genetic Diagnosis (PGD) Product Offered
11.17.3 Bioarray Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Bioarray Main Business Overview
11.17.5 Bioarray Latest Developments
11.18 Quest Diagnostics
11.18.1 Quest Diagnostics Company Information
11.18.2 Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Product Offered
11.18.3 Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Quest Diagnostics Main Business Overview
11.18.5 Quest Diagnostics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Chromosomal Abnormalities
Table 3. Major Players of Gender Selection
Table 4. Major Players of X-linked Diseases
Table 5. Major Players of Aneuploidy
Table 6. Major Players of Single Gene Disorders
Table 7. Major Players of Others
Table 8. Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
Table 11. Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
Table 14. Global Preimplantation Genetic Diagnosis (PGD) Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Player (2019-2024)
Table 16. Preimplantation Genetic Diagnosis (PGD) Key Players Head office and Products Offered
Table 17. Preimplantation Genetic Diagnosis (PGD) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Regions (2019-2024)
Table 22. Global Preimplantation Genetic Diagnosis (PGD) Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Country (2019-2024)
Table 26. Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
Table 28. Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
Table 30. APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Region (2019-2024)
Table 32. APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
Table 34. APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
Table 36. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Country (2019-2024)
Table 38. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
Table 40. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Preimplantation Genetic Diagnosis (PGD)
Table 49. Key Market Challenges & Risks of Preimplantation Genetic Diagnosis (PGD)
Table 50. Key Industry Trends of Preimplantation Genetic Diagnosis (PGD)
Table 51. Global Preimplantation Genetic Diagnosis (PGD) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Preimplantation Genetic Diagnosis (PGD) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Preimplantation Genetic Diagnosis (PGD) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Illumina Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 56. Illumina Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 57. Illumina Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Illumina Main Business
Table 59. Illumina Latest Developments
Table 60. Thermo Fisher Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 61. Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 62. Thermo Fisher Main Business
Table 63. Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Thermo Fisher Latest Developments
Table 65. Agilent Technologies Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 66. Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 67. Agilent Technologies Main Business
Table 68. Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Agilent Technologies Latest Developments
Table 70. PerkinElmer Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 71. PerkinElmer Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 72. PerkinElmer Main Business
Table 73. PerkinElmer Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. PerkinElmer Latest Developments
Table 75. Coopersurgical Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 76. Coopersurgical Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 77. Coopersurgical Main Business
Table 78. Coopersurgical Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Coopersurgical Latest Developments
Table 80. Abbott Laboratories Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 81. Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 82. Abbott Laboratories Main Business
Table 83. Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Abbott Laboratories Latest Developments
Table 85. Natera Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 86. Natera Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 87. Natera Main Business
Table 88. Natera Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Natera Latest Developments
Table 90. Takara Bio Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 91. Takara Bio Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 92. Takara Bio Main Business
Table 93. Takara Bio Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Takara Bio Latest Developments
Table 95. Oxford Gene Technology Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 96. Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 97. Oxford Gene Technology Main Business
Table 98. Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Oxford Gene Technology Latest Developments
Table 100. Yikon Genomics Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 101. Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 102. Yikon Genomics Main Business
Table 103. Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Yikon Genomics Latest Developments
Table 105. Progenesis Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 106. Progenesis Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 107. Progenesis Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Progenesis Main Business
Table 109. Progenesis Latest Developments
Table 110. Beijing Genomics Institute Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 111. Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 112. Beijing Genomics Institute Main Business
Table 113. Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Beijing Genomics Institute Latest Developments
Table 115. Invitae Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 116. Invitae Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 117. Invitae Main Business
Table 118. Invitae Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. Invitae Latest Developments
Table 120. Invicta Genetics Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 121. Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 122. Invicta Genetics Main Business
Table 123. Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. Invicta Genetics Latest Developments
Table 125. Combimatrix Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 126. Combimatrix Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 127. Combimatrix Main Business
Table 128. Combimatrix Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. Combimatrix Latest Developments
Table 130. Genea Limited Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 131. Genea Limited Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 132. Genea Limited Main Business
Table 133. Genea Limited Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 134. Genea Limited Latest Developments
Table 135. Bioarray Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 136. Bioarray Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 137. Bioarray Main Business
Table 138. Bioarray Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 139. Bioarray Latest Developments
Table 140. Quest Diagnostics Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 141. Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 142. Quest Diagnostics Main Business
Table 143. Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 144. Quest Diagnostics Latest Developments
Table 1. Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Chromosomal Abnormalities
Table 3. Major Players of Gender Selection
Table 4. Major Players of X-linked Diseases
Table 5. Major Players of Aneuploidy
Table 6. Major Players of Single Gene Disorders
Table 7. Major Players of Others
Table 8. Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
Table 11. Preimplantation Genetic Diagnosis (PGD) Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
Table 14. Global Preimplantation Genetic Diagnosis (PGD) Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Player (2019-2024)
Table 16. Preimplantation Genetic Diagnosis (PGD) Key Players Head office and Products Offered
Table 17. Preimplantation Genetic Diagnosis (PGD) Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Preimplantation Genetic Diagnosis (PGD) Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Regions (2019-2024)
Table 22. Global Preimplantation Genetic Diagnosis (PGD) Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Country (2019-2024)
Table 26. Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
Table 28. Americas Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
Table 30. APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Region (2019-2024)
Table 32. APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
Table 34. APAC Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
Table 36. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Country (2019-2024)
Table 38. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
Table 40. Europe Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Preimplantation Genetic Diagnosis (PGD)
Table 49. Key Market Challenges & Risks of Preimplantation Genetic Diagnosis (PGD)
Table 50. Key Industry Trends of Preimplantation Genetic Diagnosis (PGD)
Table 51. Global Preimplantation Genetic Diagnosis (PGD) Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Preimplantation Genetic Diagnosis (PGD) Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Preimplantation Genetic Diagnosis (PGD) Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Illumina Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 56. Illumina Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 57. Illumina Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Illumina Main Business
Table 59. Illumina Latest Developments
Table 60. Thermo Fisher Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 61. Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 62. Thermo Fisher Main Business
Table 63. Thermo Fisher Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Thermo Fisher Latest Developments
Table 65. Agilent Technologies Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 66. Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 67. Agilent Technologies Main Business
Table 68. Agilent Technologies Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Agilent Technologies Latest Developments
Table 70. PerkinElmer Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 71. PerkinElmer Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 72. PerkinElmer Main Business
Table 73. PerkinElmer Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. PerkinElmer Latest Developments
Table 75. Coopersurgical Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 76. Coopersurgical Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 77. Coopersurgical Main Business
Table 78. Coopersurgical Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Coopersurgical Latest Developments
Table 80. Abbott Laboratories Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 81. Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 82. Abbott Laboratories Main Business
Table 83. Abbott Laboratories Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Abbott Laboratories Latest Developments
Table 85. Natera Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 86. Natera Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 87. Natera Main Business
Table 88. Natera Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Natera Latest Developments
Table 90. Takara Bio Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 91. Takara Bio Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 92. Takara Bio Main Business
Table 93. Takara Bio Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Takara Bio Latest Developments
Table 95. Oxford Gene Technology Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 96. Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 97. Oxford Gene Technology Main Business
Table 98. Oxford Gene Technology Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Oxford Gene Technology Latest Developments
Table 100. Yikon Genomics Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 101. Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 102. Yikon Genomics Main Business
Table 103. Yikon Genomics Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Yikon Genomics Latest Developments
Table 105. Progenesis Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 106. Progenesis Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 107. Progenesis Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Progenesis Main Business
Table 109. Progenesis Latest Developments
Table 110. Beijing Genomics Institute Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 111. Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 112. Beijing Genomics Institute Main Business
Table 113. Beijing Genomics Institute Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Beijing Genomics Institute Latest Developments
Table 115. Invitae Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 116. Invitae Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 117. Invitae Main Business
Table 118. Invitae Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. Invitae Latest Developments
Table 120. Invicta Genetics Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 121. Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 122. Invicta Genetics Main Business
Table 123. Invicta Genetics Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. Invicta Genetics Latest Developments
Table 125. Combimatrix Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 126. Combimatrix Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 127. Combimatrix Main Business
Table 128. Combimatrix Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. Combimatrix Latest Developments
Table 130. Genea Limited Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 131. Genea Limited Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 132. Genea Limited Main Business
Table 133. Genea Limited Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 134. Genea Limited Latest Developments
Table 135. Bioarray Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 136. Bioarray Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 137. Bioarray Main Business
Table 138. Bioarray Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 139. Bioarray Latest Developments
Table 140. Quest Diagnostics Details, Company Type, Preimplantation Genetic Diagnosis (PGD) Area Served and Its Competitors
Table 141. Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Product Offered
Table 142. Quest Diagnostics Main Business
Table 143. Quest Diagnostics Preimplantation Genetic Diagnosis (PGD) Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 144. Quest Diagnostics Latest Developments
LIST OF FIGURES
Figure 1. Preimplantation Genetic Diagnosis (PGD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Preimplantation Genetic Diagnosis (PGD) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Preimplantation Genetic Diagnosis (PGD) Sales Market Share by Country/Region (2023)
Figure 8. Preimplantation Genetic Diagnosis (PGD) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type in 2023
Figure 10. Preimplantation Genetic Diagnosis (PGD) in Maternity Centers & Fertility Clinics
Figure 11. Global Preimplantation Genetic Diagnosis (PGD) Market: Maternity Centers & Fertility Clinics (2019-2024) & ($ Millions)
Figure 12. Preimplantation Genetic Diagnosis (PGD) in Hospitals, Diagnostic Labs, and Service Providers
Figure 13. Global Preimplantation Genetic Diagnosis (PGD) Market: Hospitals, Diagnostic Labs, and Service Providers (2019-2024) & ($ Millions)
Figure 14. Preimplantation Genetic Diagnosis (PGD) in Research Laboratories & Academic Institutes
Figure 15. Global Preimplantation Genetic Diagnosis (PGD) Market: Research Laboratories & Academic Institutes (2019-2024) & ($ Millions)
Figure 16. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application in 2023
Figure 17. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Player in 2023
Figure 18. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Preimplantation Genetic Diagnosis (PGD) Market Size 2019-2024 ($ Millions)
Figure 20. APAC Preimplantation Genetic Diagnosis (PGD) Market Size 2019-2024 ($ Millions)
Figure 21. Europe Preimplantation Genetic Diagnosis (PGD) Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size 2019-2024 ($ Millions)
Figure 23. Americas Preimplantation Genetic Diagnosis (PGD) Value Market Share by Country in 2023
Figure 24. United States Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Region in 2023
Figure 29. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type in 2023
Figure 30. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application in 2023
Figure 31. China Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Country in 2023
Figure 38. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
Figure 39. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
Figure 40. Germany Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 54. APAC Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 55. Europe Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 57. United States Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 58. Canada Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 61. China Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 62. Japan Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 63. Korea Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 65. India Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 66. Australia Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 67. Germany Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 68. France Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 69. UK Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 70. Italy Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 71. Russia Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 72. Spain Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 75. Israel Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 78. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Preimplantation Genetic Diagnosis (PGD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Preimplantation Genetic Diagnosis (PGD) Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Preimplantation Genetic Diagnosis (PGD) Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Preimplantation Genetic Diagnosis (PGD) Sales Market Share by Country/Region (2023)
Figure 8. Preimplantation Genetic Diagnosis (PGD) Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type in 2023
Figure 10. Preimplantation Genetic Diagnosis (PGD) in Maternity Centers & Fertility Clinics
Figure 11. Global Preimplantation Genetic Diagnosis (PGD) Market: Maternity Centers & Fertility Clinics (2019-2024) & ($ Millions)
Figure 12. Preimplantation Genetic Diagnosis (PGD) in Hospitals, Diagnostic Labs, and Service Providers
Figure 13. Global Preimplantation Genetic Diagnosis (PGD) Market: Hospitals, Diagnostic Labs, and Service Providers (2019-2024) & ($ Millions)
Figure 14. Preimplantation Genetic Diagnosis (PGD) in Research Laboratories & Academic Institutes
Figure 15. Global Preimplantation Genetic Diagnosis (PGD) Market: Research Laboratories & Academic Institutes (2019-2024) & ($ Millions)
Figure 16. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application in 2023
Figure 17. Global Preimplantation Genetic Diagnosis (PGD) Revenue Market Share by Player in 2023
Figure 18. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Preimplantation Genetic Diagnosis (PGD) Market Size 2019-2024 ($ Millions)
Figure 20. APAC Preimplantation Genetic Diagnosis (PGD) Market Size 2019-2024 ($ Millions)
Figure 21. Europe Preimplantation Genetic Diagnosis (PGD) Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size 2019-2024 ($ Millions)
Figure 23. Americas Preimplantation Genetic Diagnosis (PGD) Value Market Share by Country in 2023
Figure 24. United States Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Region in 2023
Figure 29. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type in 2023
Figure 30. APAC Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application in 2023
Figure 31. China Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Country in 2023
Figure 38. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
Figure 39. Europe Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
Figure 40. Germany Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Preimplantation Genetic Diagnosis (PGD) Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 54. APAC Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 55. Europe Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 57. United States Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 58. Canada Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 61. China Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 62. Japan Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 63. Korea Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 65. India Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 66. Australia Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 67. Germany Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 68. France Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 69. UK Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 70. Italy Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 71. Russia Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 72. Spain Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 75. Israel Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Preimplantation Genetic Diagnosis (PGD) Market Size 2025-2030 ($ Millions)
Figure 78. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Preimplantation Genetic Diagnosis (PGD) Market Size Market Share Forecast by Application (2025-2030)
